This HTML5 document contains 138 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n8http://dx.doi.org/10.1001/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q42687183
rdf:type
wikibase:Item
schema:description
naučni članak 2002年论文 2002年論文 scienca artikolo vědecký článek artigo científico artículu científicu espublizáu en 2002 2002年论文 2002년 논문 bilimsel makale სამეცნიერო სტატია 2002 nî lūn-bûn 2002年論文 наукова стаття, опублікована в листопаді 2002 scientific article published on November 2002 научни чланак vitskapeleg artikkel artikel ilmiah tudományos cikk บทความทางวิทยาศาสตร์ 2002年论文 2002年論文 artigo científico articol științific 2002年の論文 article scientifique wetenschappelijk artikel artikull shkencor научна статия مقالة علمية نشرت في نوفمبر 2002 teaduslik artikkel мақолаи илмӣ 2002年論文 vedecký článok vitenskapelig artikkel 2002年论文 wissenschaftlicher Artikel artykuł naukowy artigo científico scientific article published on November 2002 artículo científico publicado en 2002 επιστημονικό άρθρο 2002年论文 2002年论文 научни чланак videnskabelig artikel article científic tieteellinen artikkeli bài báo khoa học নভেম্বর ২০০২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ מאמר מדעי 2002年論文 مقالة علمية تنشرت ف 1 نونبر 2002 artikulong pang-agham vetenskaplig artikel scientific article published on November 2002 article scientific articolo scientifico научная статья
p:P577
wds:Q42687183-24C890A2-E90E-4098-8CA0-A83EF3B3E5F2
wdt:P577
2002-11-01T00:00:00Z
p:P407
wds:Q42687183-BF3B58DE-A614-4230-96E6-DD6ADDE9F789
wdt:P407
wd:Q1860
p:P2093
wds:Q42687183-4A87D1F4-C69D-4D51-B299-5A50A6979A5E wds:Q42687183-42DC6188-B8EC-4377-9B98-D46F94F5EA71 wds:Q42687183-4369D2E1-C664-4C5C-9D2B-A20096784C03 wds:Q42687183-3E68157C-C0F7-4B0E-BB1A-159791A18AAE wds:Q42687183-34DF690C-9242-4CA4-B4EA-1E77EE68DD5F wds:Q42687183-E0AF5DE1-816F-4858-BD00-D4241AC1A293 wds:Q42687183-CB8FBE12-BE75-4072-98F6-53AAB768D52B
wdt:P2093
James T Willerson Global Use of Strategies To Open Coronary Arteries Investigators (GUSTO) Alec Vahanian Stefano Savonitto Joan E Booth Michael Waller Frits Bar
rdfs:label
Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial
skos:prefLabel
Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial
schema:name
Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial
p:P50
wds:Q42687183-E583DD60-79A7-4531-9583-17583BD0439E wds:Q42687183-E8F67EB0-6A08-4786-BF73-7D8C653D34A8 wds:Q42687183-DC516746-940D-4FB6-8C7C-1EF2D8CBA391 wds:Q42687183-EC977ACB-D629-40D2-AF6E-A1054205A0D4 wds:Q42687183-4F69DD35-4488-4164-99F7-ABD976271D0F wds:Q42687183-53061160-BF00-42D1-95AE-58E10632BC12 wds:Q42687183-5FE2B316-DD13-41D3-B2E2-68C2F340D8DA wds:Q42687183-7562C31D-2C7C-497B-B381-169795CD0A30 wds:Q42687183-79143A08-8CA1-4D06-8877-929AD35DED42 wds:Q42687183-7B998EF6-1A69-484C-B49B-BDD8FF5B2CC8 wds:Q42687183-B340E3A4-4B13-4E88-9F48-68B2B20AA04B wds:Q42687183-08C47D59-B62D-4BEC-A641-611FAA3016E1 wds:Q42687183-39DFDBFB-A60B-4845-AAA2-CF2ABFFAD74C wds:Q42687183-3A7C7FD8-2B7C-4B6E-BD69-E5807813D169 wds:Q42687183-0E297105-7FFC-4AF7-AA84-A8746695999C
wdt:P50
wd:Q60457714 wd:Q5492406 wd:Q114292227 wd:Q39730635 wd:Q98148342 wd:Q62070116 wd:Q39026591 wd:Q19281782 wd:Q1587897 wd:Q16027739 wd:Q114292228 wd:Q91861722 wd:Q63038136 wd:Q5387640 wd:Q60318964
p:P1476
wds:Q42687183-3F90ECF8-C712-4435-89FD-23622F2171D9
wdt:P1476
Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial
p:P304
wds:Q42687183-FF718733-05B5-4AF7-AC92-BBFBC60603D8
wdt:P304
2130-2135
p:P31
wds:Q42687183-52002974-0E1B-40D9-A7F7-683F9A559CE9
wdt:P31
wd:Q13442814
p:P921
wds:Q42687183-43FEF9D5-FCE1-4AC2-9E31-FB293119184C wds:Q42687183-2DC148FB-5C05-458C-B2AD-EFD9807A229E
wdt:P921
wd:Q12152 wd:Q18558122
p:P698
wds:Q42687183-D7F6FE64-AE93-4A40-AB52-AA981752D65E
wdtn:P698
n12:12413372
wdt:P698
12413372
p:P1433
wds:Q42687183-CC1866EE-303F-4C34-99B6-F812A5697FFB
wdt:P1433
wd:Q1470970
p:P433
wds:Q42687183-E80F6CBB-740B-4AB1-906C-A39C06CA35E2
p:P478
wds:Q42687183-BB6D181B-9D0D-41A7-8453-6F44A98D10A5
wdt:P433
17
wdt:P478
288
p:P356
wds:Q42687183-C008996E-5D31-45A0-8EBF-0E0C28B47F78
wdtn:P356
n8:JAMA.288.17.2130
wdt:P356
10.1001/JAMA.288.17.2130
p:P5875
wds:Q42687183-DB012AF1-DC6E-43A0-8661-39F148C8D933
wdt:P5875
11052565